U.S. Markets closed

Conatus: 3Q Earnings Snapshot

SAN DIEGO (AP) _ Conatus Pharmaceuticals Inc. (CNAT) on Tuesday reported a loss of $3.3 million in its third quarter.

The San Diego-based company said it had a loss of 10 cents per share.

The biotechnology company posted revenue of $3.4 million in the period.

In the final minutes of trading on Tuesday, the company's shares hit 35 cents. A year ago, they were trading at $5.23.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNAT at https://www.zacks.com/ap/CNAT